Testing effectiveness (Phase 2)Study completedNCT03594058
What this trial is testing
Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)
Who this might be right for
Overactive Bladder
Velicept Therapeutics, Inc. 1,413